Legacy Research Institute

STEVEN L. MANSBERGER, M.D., M.P.H.

Chenoweth Chair of Ophthalmology, Director of Glaucoma Services, Director of Glaucoma Fellowship, Legacy Devers Eye Institute
Senior Scientist, Discoveries in Sight, Legacy Research Institute
Clinical Vice-President, Legacy Health

Phone: 503-413-8202 | Email: smansberger@deverseye.org

CV (updated May 2024)  |  Peer reviewed publications
Discoveries in Sight Laboratories
Devers Eye Institute  |  Legacy Health Provider Profile
https://orcid.org/0000-0002-5208-3544

SHORT BIO:

Steven L. Mansberger, MD, MPH is Chair, Senior Scientist, and Director of ophthalmic clinical trials for Legacy Devers Eye Institute in Portland, Oregon. He is also director of the glaucoma fellowship program and director of the glaucoma service. He holds appointments at Oregon Health Science University (OHSU) as Clinical Professor of Ophthalmology and Public Health and Preventive Medicine.

Dr. Mansberger completed his medical degree from Indiana University School of Medicine, an ophthalmology residency at Shiley Eye Center at the University of California, San Diego, and a glaucoma fellowship at Devers Eye Institute. He also earned a Masters in Public Health degree (MPH-Biostatistics/Epidemiology) from OHSU.

Dr. Mansberger has been continuously funded by the National Eye Institute since 2000 with over 30 other research grants including foundations and industry. He has won numerous awards including “Best Doctors in Portland, OR”, “Best Doctors in America”, Heed Fellowship, The Robert Watske Ophthalmology Instructor of the Year, American Glaucoma Society Clinician-Scientist award, among others. He is on the Editorial Boards of Journal of Glaucoma and American Journal of Ophthalmology, and is the Section Editor for epidemiology/glaucoma at American Journal of Ophthalmology. He is an invited reviewer for Archives of Ophthalmology, British Journal of Ophthalmology, Ophthalmology, Investigative Ophthalmology and Visual Science, Survey of Ophthalmology, as well as multiple other journals. He has authored over 300 journal articles, book chapters, and abstracts.

PUBLICATION HIGHLIGHTS:

OCT Segmentation Errors with Bruch's Membrane Opening-Minimum Rim Width as Compared with Retinal Nerve Fiber Layer Thickness.
Yang H, Rees JP, Sanchez FG, Gardiner SK, Mansberger SL.
Ophthalmol Glaucoma. 2024 May-Jun;7(3):308-315.  
https://pubmed.ncbi.nlm.nih.gov/38104770/

Intraocular Pressure and Medication Burden With Cataract Surgery Alone, or Cataract Surgery Combined With Trabecular Bypass or Goniotomy.
McNiel CL, Sanchez FG, Rees JP, Gardiner SK, Young JW, Kinast RM, Young A, Jones EP, Mansberger SL.
Glaucoma. 2022 Jun 1;31(6):423-429.
https://pubmed.ncbi.nlm.nih.gov/35353775/

Geospatial analysis of blindness within rural and urban counties.
Sanchez FG, Gardiner SK, Demirel S, Rees JP, Mansberger SL.
PLoS One. 2022 Oct 10;17(10):e0275807. PMCID: PMC9550029.
https://pubmed.ncbi.nlm.nih.gov/36215279/

Cataract Surgery Lowers Intraocular Pressure and Medication Use in the Medication Group of the Ocular Hypertension Treatment Study.
Mansberger SL, Gardiner SK, Gordon M, Kass M, Ramulu P; Ocular Hypertension Treatment Study group.
Am J Ophthalmol. 2022 Apr;236:53-62. PMCID: PMC8761780.
https://pubmed.ncbi.nlm.nih.gov/34280363/

RESEARCH INTERESTS:

• Functional testing of glaucoma
• Prevalence of eye disease in populations
• Health behavior as it relates to glaucoma medication adherence
• Eye drop administration
• Biostatistics and epidemiology

RESEARCH FOCUS:

We focus our efforts on: health behavior as it relates to eye disease; advanced biostatistics to advance the evaluation and interpretation of ophthalmology data; clinical trials to predict individual and group responses to interventions; glaucoma medication adherence; and studies to examine the effectiveness of interventions on individuals, communities, and health systems.